SCHEMBL18445807

SCHEMBL18445807

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOC(C)CC1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.81
BRAF P15056 2/20 0.81
KDR P35968 2/20 0.81
EPHB4 P54760 2/20 0.81
CIT O14578 1/20 0.81
GAK O14976 1/20 0.81
EPHB6 O15197 1/20 0.81
ABCC4 O15439 1/20 0.81
DAPK3 O43293 1/20 0.81
RIPK2 O43353 1/20 0.81
NR1I2 O75469 1/20 0.81
RPS6KA4 O75676 1/20 0.81
STK17B O94768 1/20 0.81
STK10 O94804 1/20 0.81
PRKD3 O94806 1/20 0.81
ABCB11 O95342 1/20 0.81
MAP4K4 O95819 1/20 0.81
CHEK2 O96017 1/20 0.81
ABL1 P00519 1/20 0.81
ERBB2 P04626 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gefitinib SCHEMBL29351046 0.90 EGFR (1.00) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL29351336 0.90 EGFR (1.00) EGFRBRAFKDREPHB4CIT
SCHEMBL1734701 0.90 EGFR (1.00) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL7866 0.90 EGFR (1.00) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL465143 0.90 EGFR (1.00) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL2770155 0.89 EGFR (0.98) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL29371159 0.89 EGFR (0.98) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL28097850 0.89 EGFR (0.98) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL28098790 0.89 EGFR (0.98) EGFRBRAFKDREPHB4CIT
Gefitinib SCHEMBL11776 0.89 EGFR (0.98) EGFRBRAFKDREPHB4CIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2518063-B1 Pyridazinones and furan-containing compounds SLOAN-KETTERING INST FOR CANCER RES (US) 2017-02-01 EP disclosed